Search

everythinglearnresearchcommunity

for

Search:↓

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Finasteride safely reduces excessive hair growth in women.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Effective treatments for severe alopecia areata are still lacking.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Treatments for melanin disorders exist, but more effective options needed.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Most women with excessive hair growth have a hormonal cause.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.